These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

350 related items for PubMed ID: 8200011

  • 1. [Efficacy and tolerability of simvastatin and omega-3 fatty acid combination in patients with coronary disease, hypercholesterolemia and hypertriglyceridemia].
    Tomei R, Rossi L, Carbonieri E, Franceschini L, Cemin C, Ghebremariam-Tesfau K, Zardini P.
    Cardiologia; 1993 Dec; 38(12):773-8. PubMed ID: 8200011
    [Abstract] [Full Text] [Related]

  • 2. [Effectiveness and tolerability of simvastatin in patients with moderate-to-severe hypercholesterolemia. Results of a 12-month study].
    Ghizzoni G, Rusconi C, Faggiano P, Sabatini T, Oneglia C, Gardini A.
    Minerva Cardioangiol; 1993 Mar; 41(3):105-9. PubMed ID: 8510811
    [Abstract] [Full Text] [Related]

  • 3. [Therapy of hypercholesterolemia and hypertriglyceridemia. Comparison of the lipid-lowering effect of simvastatin and tiadenol].
    Serra T, Gavelli MS, Vitaliano E, Santini G, Catalano A, Rossi FG, Tozzi J, Caridis R, Guarini G.
    Clin Ter; 1990 Mar 15; 132(5):307-13. PubMed ID: 2139833
    [Abstract] [Full Text] [Related]

  • 4. Lipid-lowering effects of simvastatin and gemfibrozil in CAPD patients: a prospective cross-over study.
    Akçiçek F, Ok E, Duman S, Kürsad S, Unsal A, Alev M, Atabay G, Basçi A.
    Adv Perit Dial; 1996 Mar 15; 12():261-5. PubMed ID: 8865916
    [Abstract] [Full Text] [Related]

  • 5. Effects of adding prescription omega-3 acid ethyl esters to simvastatin (20 mg/day) on lipids and lipoprotein particles in men and women with mixed dyslipidemia.
    Maki KC, McKenney JM, Reeves MS, Lubin BC, Dicklin MR.
    Am J Cardiol; 2008 Aug 15; 102(4):429-33. PubMed ID: 18678300
    [Abstract] [Full Text] [Related]

  • 6. [Long term treatment of moderate to severe hypercholesterolemia with low dose statin. Comparison of simvastatin and pravastatin].
    Spagnolli W, Ramponi C, Focher C, Dal Piaz A, Torboli P, Miori R, De Venuto G.
    Recenti Prog Med; 1996 Nov 15; 87(11):538-42. PubMed ID: 9122535
    [Abstract] [Full Text] [Related]

  • 7. [Can hyperlipidemia after heart transplantation be optimally and safely treated?].
    Wenke K, Thiery J, Arndtz N, Seidel D, Reichart B.
    Helv Chir Acta; 1994 Dec 15; 60(6):1163-8. PubMed ID: 7875999
    [Abstract] [Full Text] [Related]

  • 8. Comparative efficacy and safety of micronized fenofibrate and simvastatin in patients with primary type IIa or IIb hyperlipidemia.
    Farnier M, Bonnefous F, Debbas N, Irvine A.
    Arch Intern Med; 1994 Feb 28; 154(4):441-9. PubMed ID: 8117177
    [Abstract] [Full Text] [Related]

  • 9. [Simvastatin versus gemfibrozil in the treatment of primary hypercholesterolemia in hypertensive patients treated with hydrochlorothiazide].
    Berioli S, Bentivoglio M, Conti R, Osanna RA, Savino K, Zollino L, Corea L.
    Cardiologia; 1990 Apr 28; 35(4):335-40. PubMed ID: 2245435
    [Abstract] [Full Text] [Related]

  • 10. [Therapy of hypercholesterolemia after heart transplantation with the HMG-CoA reductase inhibitor simvastatin in long-term follow-up].
    Wenke K, Thiery J, Meiser B, Arndtz N, Seidel D, Reichart B.
    Z Kardiol; 1995 Feb 28; 84(2):130-6. PubMed ID: 7717016
    [Abstract] [Full Text] [Related]

  • 11. Simvastatin therapy for hypercholesterolaemia in patients with coronary heart disease.
    French JK, White HD, Greaves SC.
    N Z Med J; 1990 Feb 14; 103(883):41-3. PubMed ID: 2304688
    [Abstract] [Full Text] [Related]

  • 12. [Effects and side effects of a 1-year treatment of primary hypercholesterolemia with simvastatin].
    Brocard JJ, Keller U, Oberhänsli A, Riesen WF.
    Schweiz Med Wochenschr; 1991 Jun 29; 121(26):977-83. PubMed ID: 1862314
    [Abstract] [Full Text] [Related]

  • 13. Comparison of the short term efficacy and tolerability of lovastatin and simvastatin in the management of primary hypercholesterolemia.
    Frohlich J, Brun LD, Blank D, Campeau L, Crockford P, Curnew G, Dafoe W, Davignon J, Dufour R, Emery G.
    Can J Cardiol; 1993 Jun 29; 9(5):405-12. PubMed ID: 8348392
    [Abstract] [Full Text] [Related]

  • 14. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR, Gandhi S, Blasetto J, Heien H, Sasane R, Nelson SP.
    Am J Geriatr Pharmacother; 2007 Sep 29; 5(3):185-94. PubMed ID: 17996658
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and tolerability of adding prescription omega-3 fatty acids 4 g/d to simvastatin 40 mg/d in hypertriglyceridemic patients: an 8-week, randomized, double-blind, placebo-controlled study.
    Davidson MH, Stein EA, Bays HE, Maki KC, Doyle RT, Shalwitz RA, Ballantyne CM, Ginsberg HN, COMBination of prescription Omega-3 with Simvastatin (COMBOS) Investigators.
    Clin Ther; 2007 Jul 29; 29(7):1354-67. PubMed ID: 17825687
    [Abstract] [Full Text] [Related]

  • 16. [Multicenter comparative study on safety, tolerance, and effectiveness of lovastatin combined or not with cholestyramine, and gemfibrozil combined or not with cholestyramine in the treatment of primary hypercholesterolemia].
    Jover E, Aranda JL, Nogués X, del Palacio A, Rubiés-Prat J.
    Med Clin (Barc); 1996 May 25; 106(20):776-9. PubMed ID: 8801396
    [Abstract] [Full Text] [Related]

  • 17. [Effectiveness, tolerance and safety of simvastatin in comparison with bezafibrate in treatment of hypercholesterolemia].
    Lechleitner M, Sailer S, Irsigler H, Klein W, Patsch JR.
    Wien Med Wochenschr; 1995 May 25; 145(21):577-83. PubMed ID: 8560901
    [Abstract] [Full Text] [Related]

  • 18. [Effects of simvastatin on atherogenic blood lipid pattern].
    Alessandri C, Peverini F, Basili S, Barsi R, Paradiso M, Marotta P, Censi C, Cordova C, Balsano F.
    Recenti Prog Med; 1991 Apr 25; 82(4):225-9. PubMed ID: 1857842
    [Abstract] [Full Text] [Related]

  • 19. [Simvastatin (MK-733), a new HMG-CoA reductase inhibitor, in the treatment of hypercholesterolemia in elderly patients with atherosclerosis].
    Giannini SD, de Góes JM, Dereviack BE, Machado C, Forti N, Diament J.
    Arq Bras Cardiol; 1990 Jun 25; 54(6):407-14. PubMed ID: 2288531
    [Abstract] [Full Text] [Related]

  • 20. Effects of bezafibrate and of 2 HMG-CoA reductase inhibitors on lipoprotein (a) level in hypercholesterolemic patients.
    Branchi A, Rovellini A, Fiorenza AM, Sommariva D.
    Int J Clin Pharmacol Ther; 1995 Jun 25; 33(6):345-50. PubMed ID: 7582386
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.